Development of games using neurofeedback which improve the concentration of children with ADHD.
Cortechs is addressing an exponentially growing brain-based health challenge impacting over 2 billion people and 1 in 9 children worldwide: the inability to reach the basic cognitive skill levels needed to maintain the attention needed for school, work, home and life.
Cortechs create data-driven, therapeutic games that use cognitive training and brainwaves to improve attention levels in children with Attention Deficit Hyperactivity Disorder (ADHD). The games use fun tasks to improve attention deficit; brainwaves can be remotely assessed by specialist clinicians to prescribe game tasks via secure web dashboards to parents and children.
Products and Services
Building on the success of the product Zip and the Misty Mountain (200+ sales), we are currently commercialising a consumer-facing enterprise platform called CereBrill to treat attention deficit.
Cortechs could significantly cut treatment costs (72%) in children aged 0-10 with ADHD. In addition to cost-benefits, CereBrill value add would reduce behavioural interventions, reduce medication/clinical visits and free up clinician schedules.
ADHD is expensive, causes suffering and impairs social productivity. A child with ADHD has a reduced ability to pay attention to what is being taught in class, to follow instructions, to organize schoolwork and manage his/her time efficiently, and even to plan for future events. All these behaviours often result in negative attention from teachers, parents, and others, which has a detrimental impact on a child’s self-confidence and motivation to learn.
The current systems for treating ADHD are suboptimal and fail the person suffering with ADHD. Cortechs can provide a reliable measurement of the user’s behaviour journey.
The reality of the ADHD Market is that access is difficult, treatment review is generally qualitative and the treatment cost so prohibitive, especially innovative treatments not readily available in the public systems.
There are four treatments currently available for ADHD:
ADHD treatments pose large societal and economic costs. The pain point of medication for ADHD families is that it does not improve the core cognitive skills of attention deficit affected in ADHD.
There is no validated, combined treatment paradigm available to the ADHD family or caregiver that can offer treatment in an accessible and cost-effective manner.
Cortechs can add value to the Quality of Life of the patients and free up time for the physician.
We can do this at a reduced cost and risk for the children or healthcare provider.
A market opportunity exists here for Cortechs to offer an innovative and non-invasive method for treating and reliably measuring the unmet, health needs in ADHD.
MedTech, Wellness, Gaming, Education, Neurofeedback
Aviva, Holtzbrinck Publishers, NDRC and Enterprise Ireland (EI), Barcelona Hospital SJD, Microsoft, BioExcel NUIG.
Geographical Market(s) Served
Ireland, UK, USA, Canada, Germany.
125 Belfry Hall